<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Supp/Evening_Primrose_Oil.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:31:35 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="2841007">
<meta name="Category" content="Supp">
<meta name="Article" content="Evening_Primrose_Oil">
<title>Aceite de Onagra-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Aceite de Onagra</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Evening_Primrose_Oil.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Joe LA, Hart LL. Evening primrose oil in rheumatoid arthritis. <em>Ann
Pharmacother</em> 1993;27:1475-7 [review].</li>

<li class="Ref">Dippneaar N, Booyens J, Fabbri D, Katzeff IE. The reversibility of cancer:
evidence that malignancy in melanoma cells is gamma linolenic acid deficiency-dependent. <em>S
Afr Med J</em> 1982;62:505-9.</li>

<li class="Ref">Pritchard GA, Mansel RE. The effects of essential fatty acids on the growth of
breast cancer and melanoma. In <em>Omega-6 Essential Fatty Acids: Pathophysiology and Roles in
Clinical Medicine</em>. Horrobin DF (ed). New York: Alan R Liss, 1990, 379-90.</li>

<li class="Ref">Lee JH, Sugano M. Effects of linoleic and gamma-linolenic acid on
7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. <em>Nutr Rep Int</em>
1986;34:1041.</li>

<li class="Ref">Naidu MRC, Das UN, Kshan A. Intratumoral gamma-linolenic acid therapy of human
gliomas. <em>Prostaglandins Leukot Essent Fatty Acids</em> 1992;45:181-4.</li>

<li class="Ref">Van der Merwe CF, Booyens J. Oral gamma-linolenic acid in 21 patients with
untreatable malignancy. An ongoing pilot open clinical trial. <em>Br J Clin Pract</em>
1987;41:907-15.</li>

<li class="Ref">McIllmurray MB, Turkie W. Controlled trial of gamma linolenic in Duke&#8217;s
C colorectal cancer. <em>Br Med J</em> 1987;294:1260.</li>

<li class="Ref">Ishikawa T, Fujiyama Y, Igarashi O, et al. Effects of gammalinolenic acid on
plasma lipoproteins and apolipoproteins. <em>Atherosclerosis</em> 1989;75:95-104.</li>

<li class="Ref">Boberg M, Vessby B, Selinus I. Effects of dietary supplementation with n-6 and
n-3 long-chain polyunsaturated fatty acids on serum lipoproteins and platelet function in
hypertriglyceridaemic patients. <em>Acta Med Scand</em> 1986;220:153-60.</li>

<li class="Ref">Yoshimoto-Furuie K, Yoshimoto K, Tanaka T, et al. Effects of oral
supplementation with evening primrose oil for six weeks on plasma essential fatty acids and
uremic skin symptoms in hemodialysis patients. <em>Nephron</em> 1999;81:151-9.</li>

<li class="Ref">Tamimi NA, Mikhail AI, Stevens PE. Role of gamma-linolenic acid in uraemic
pruritus. <em>Nephron</em> 1999;83:170-1 [letter].</li>

<li class="Ref">Horrobin DF. The importance of gamma-linolenic acid and prostaglandin E1 in
human nutrition and medicine. <em>J Holistic Med</em> 1981;3:118-39.</li>

<li class="Ref">Horrobin DF, Manku M, Brush M, et al. Abnormalities in plasma essential fatty
acid levels in women with pre-menstrual syndrome and with non-malignant breast disease. <em>J
Nutr Med</em> 1991;2:259&#8211;64.</li>

<li class="Ref">Keen H, Payan J, Allawi J, et al. Treatment of diabetic neuropathy with
gamma-linolenic acid. <em>Diabetes Care</em> 1993;16:8&#8211;15.</li>

<li class="Ref">Horrobin DF. Essential fatty acid metabolism in diseases of connective tissue
with special reference to scleroderma and to Sjogren&#8217;s syndrome. <em>Med Hypotheses</em>
1984;14:233&#8211;47.</li>

<li class="Ref">Horrobin DF, Campbell A. Sjogren&#8217;s syndrome and the sicca syndrome: the
role of prostaglandin E1 deficiency. Treatment with essential fatty acids and vitamin C. <em>
Med Hypotheses</em> 1980;6:225&#8211;32.</li>

<li class="Ref">Vaddadi KS, Gilleard CJ. Essential fatty acids, tardive dyskinesia, and
schizophrenia. In <em>Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical
Medicine,</em> ed. DF Horrobin. New York: Alan R Liss, 1990, 333&#8211;43.</li>

<li class="Ref">Manku MS, Horrobin, DF, Morse NL, et al. Essential fatty acids in the plasma
phospholipids of patients with atopic eczema. <em>Br J Derm</em> 1984;110:643.</li>

<li class="Ref">Horrobin DF. Essential fatty acids in clinical dermatology. <em>J Am Acad
Dermatol</em> 1989;20:1045&#8211;53.</li>

<li class="Ref">Mansel RE, Pye JK, Hughes LE. Effects of essential fatty acids on cyclical
mastalgia and noncyclical breast disorders. In <em>Omega-6 Essential Fatty Acids:
Pathophysiology and Roles in Clinical Medicine,</em> ed. DF Horrobin. New York: Alan R Liss,
1990, 557&#8211;66.</li>

<li class="Ref">Keen H, Payan J, Allawi J, et al. Treatment of diabetic neuropathy with
gamma-linolenic acid. <em>Diabetes Care</em> 1993;16:8&#8211;15.</li>

<li class="Ref">Horrobin DF. Essential fatty acid metabolism in diseases of connective tissue
with special reference to scleroderma and to Sjogren&#8217;s syndrome. <em>Med Hypotheses</em>
1984;14:233&#8211;47.</li>

<li class="Ref">Vaddadi KS, Gilleard CJ. Essential fatty acids, tardive dyskinesia, and
schizophrenia. In <em>Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical
Medicine</em>. Horrobin DF (ed). New York: Alan R Liss, 1990, 333&#8211;43.</li>

<li class="Ref">Schalin-Karrila M, Mattila L, Jansen CT, et al. Evening primrose oil in the
treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and
circulating blood prostaglandins. <em>Br J Dermatol</em> 1987;117:11&#8211;9.</li>

<li class="Ref">Glen AIM, Glen EMT, MacDonnell LEF, et al. Essential fatty acids in the
management of withdrawal symptoms and tissue damage in alcoholics, presented at the 2nd
International Congress on Essential Fatty Acids, Prostaglandins and Leukotrienes, London,
Zoological Society. March 24&#8211;7, 1985, [abstract 53].</li>

<li class="Ref">Vaddadi KS. The use of gamma-linolenic acid and linoleic acid to differentiate
between temporal lobe epilepsy and schizophrenia. <em>Prostaglandins Med</em>
1981;6:375&#8211;9.</li>

<li class="Ref">Holman CP, Bell AFJ. A trial of evening primrose oil in the treatment of
chronic schizophrenia. <em>J Orthomol Psychiatr</em> 1983;12:302&#8211;4.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Supp/Evening_Primrose_Oil.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:31:35 GMT -->
</html>

